Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 183

Results For "Eni"

2491 News Found

Cipla bags Pharma Leader of the Year award
News | April 28, 2022

Cipla bags Pharma Leader of the Year award

Glenmark Pharmaceuticals won Innovation of the Year award


Ross Prize awarded to mRNA technology, Covid-19 vaccine innovators
News | April 28, 2022

Ross Prize awarded to mRNA technology, Covid-19 vaccine innovators

University of Pennsylvania scientists Katalin Karikó and Drew Weissman to be honoured at June 7 symposium in New York City for their research that enabled Covid-19 vaccines


Kapruvia approved by European Commission for hemodialysis patients
Drug Approval | April 28, 2022

Kapruvia approved by European Commission for hemodialysis patients

First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients


Syngene full-year revenue from operations up 19% to Rs. 2604 crore
News | April 27, 2022

Syngene full-year revenue from operations up 19% to Rs. 2604 crore

Revenue from operations up 15% to Rs. 758 crore in fourth quarter


Malaysia awards three-year contract for Biocon Biologics’ Insugen
Biotech | April 26, 2022

Malaysia awards three-year contract for Biocon Biologics’ Insugen

Biocon Biologics’ Insugen formulations will be available to patients at all Ministry of Health hospitals, district health offices and health clinics


Biocytogen signs RenMab/RenLite licensing agreement with BeiGene
Biotech | April 26, 2022

Biocytogen signs RenMab/RenLite licensing agreement with BeiGene

In addition, common light chain antibodies generated by RenLite mice can greatly improve the efficiency of downstream assembly of complex drug molecules such as bispecific antibodies and bispecific antibody-drug conjugates (bsADCs)


Lonza and Integral Molecular partner on biotherapeutics
News | April 26, 2022

Lonza and Integral Molecular partner on biotherapeutics

The respective expertise of Lonza and Integral Molecular will benefit drug developers in the assessment of the risk for off-target binding and activation


SRL Diagnostics opens state-of-the-art laboratory in Jamshedpur
Clinical Trials | April 26, 2022

SRL Diagnostics opens state-of-the-art laboratory in Jamshedpur

The new lab in the industrial town is SRL’s 4th lab in the state of Jharkhand


Sygnature Discovery acquires Peak Proteins
Biotech | April 26, 2022

Sygnature Discovery acquires Peak Proteins

Peak Proteins has collaborated closely with Sygnature Discovery for several years and together the companies have supported a number of integrated drug discovery programmes


GSK launches once daily, single inhaler-triple therapy for COPD patients
Drug Approval | April 26, 2022

GSK launches once daily, single inhaler-triple therapy for COPD patients

Trelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated with less inhaler teaching time compared to other commonly used inhalers